Acelity partners with Mediq to strengthen its offering in Europe
Posted: 19 February 2016 | | No comments yet
Acelity has announced a partnership with Mediq to exclusively distribute Acelity’s advanced wound care and regenerative medicine portfolio in Denmark, Finland, Norway and Sweden.
The alliance offers Acelity access to Mediq’s specialised knowledge, expertise and network in the region and allows Acelity to expand operations in the post-acute environment.
Commenting on the alliance, Laura Piccinini, President, Acelity Developed Markets, said: “This new strategic partnership strengthens and expands our European presence by combining Acelity’s industry-leading portfolio in advanced wound care and regenerative medicine with Mediq’s broad-based distribution network in the region. Mediq’s scale provides Acelity with unparalleled access to healthcare professionals, ultimately ensuring that our products are more readily available to the patients who need them.”
The partnership leverages Mediq’s extensive experience in increasing access-to-care by offering integrated, high-quality healthcare services in a variety of settings including hospitals and care institutions, pharmacies and patients’ homes.
Joergen Kelkjaer, Executive Vice President Nordics & Baltics, Mediq, said: “This partnership with Acelity will allow us to strengthen our offering to the patients we serve by providing them a full range of leading advanced wound care and regenerative medicine products.”
Subject to the appropriate employee consultation processes now underway, the agreement is anticipated to be completed by 1 March 2016.